Novel suppressive effects of cardamonin on the activity and expression of transglutaminase-2 lead to blocking the migration and invasion of cancer cells

Life Sciences

Volumn 92, Issue 2, 2013, Pages 154-160

  Park, Mi Kyung ^a   Jo, Seung Ho ^b   Lee, Hye Ja ^a   Kang, June Hee ^a   Kim, You Ri ^a   Kim, Hyun Ji ^a   Lee, Eun Ji ^a   Koh, Jae Young ^c   Ahn, Kyung Ok ^b   Jung, Kyung Chae ^b   Oh, Seung Hyun ^d   Kim, Soo Youl ^b   Lee, Chang Hoon ^a  

^a Dongguk University   (South Korea)

^b National Cancer Center   (South Korea)

^c AmorePacific Corporation   (South Korea)

^d Gachon University College of Medicine   (South Korea)

Author keywords

Cardamonin; Invasion; Matrix metalloproteinases; Migration; NF B; Transglutaminase 2

Indexed keywords

ALPINETIN; ALPINIA KATSUMADAI EXTRACT; ANTINEOPLASTIC AGENT; CARDAMONIN; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PLANT EXTRACT; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL INVASION; CELL MIGRATION; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE SILENCING; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; WESTERN BLOTTING; ZYMOGRAPHY;

CELL LINE, TUMOR; CELL MIGRATION ASSAYS; CELL MOVEMENT; CHALCONES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GTP-BINDING PROTEINS; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NF-KAPPA B; TRANSGLUTAMINASES;

ALPINIA KATSUMADAI;

EID: 84872356718     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2012.11.009     Document Type: Article

References (36)

1. M.A. Antonyak, B. Li, A.D. Regan, Q. Feng, S.S. Dusaban, and R.A. Cerione Tissue transglutaminase is an essential participant in the epidermal growth factor-stimulated signaling pathway leading to cancer cell migration and invasion J Biol Chem 284 2009 17914 17925
2. D.S. Cha, T.Y. Shin, J.S. Eun, D.K. Kim, and H. Jeon Anti-metastatic properties of the leaves of Eriobotrya japonica Arch Pharm Res 34 2011 425 436
3. S.H. Chen, C.Y. Lin, L.T. Lee, G.D. Chang, P.P. Lee, and C.C. Hung Up-regulation of fibronectin and tissue transglutaminase promotes cell invasion involving increased association with integrin and MMP expression in A431 cells Anticancer Res 30 2010 4177 4186
4. J.K. Choi, K.M. Kim, D.K. Kim, M.H. Yeom, J.Y. Koh, and S.J. Jung Topical anti-inflammatory and antipruritic effects of Alpinia katsumadai extracts J Dermatol Sci 53 2009 81 84
5. J.K. Choi, K.M. Kim, M.H. Yeom, H.Y. Cho, H.J. Lee, and M.K. Park Antinociceptive effects of Alpinia katsumadai via cyclooxygenase-2 inhibition Biomol Ther 18 2010 159 165
6. C.M. Choi, S.J. Jang, S.Y. Park, Y.B. Choi, J.H. Jeong, and D.S. Kim Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer Mol Cancer 10 2011 119
7. Y.L. Chow, K.H. Lee, S. Vidyadaran, N.H. Lajis, M.N. Akhtar, and D.A. Israf Cardamonin from Alpinia rafflesiana inhibits inflammatory responses in IFN-gamma/LPS-stimulated BV2 microglia via NF-kappaB signalling pathway Int Immunopharmacol 12 2012 657 665
8. J.Y. Fok, S. Ekmekcioglu, and K. Mehta Implications of tissue transglutaminase expression in malignant melanoma Mol Cancer Ther 5 2006 1493 1503
9. J.E. Folk, and P.W. Cole Structural requirements of specific substrates for guinea pig liver transglutaminase J Biol Chem 240 1965 2951 2960
10. S. Hatziieremia, A.I. Gray, V.A. Ferro, A. Paul, and R. Plevin The effects of cardamonin on lipopolysaccharide-induced inflammatory protein production and MAP kinase and NFkappaB signalling pathways in monocytes/macrophages Br J Pharmacol 149 2006 188 198
11. D.A. Israf, T.A. Khaizurin, A. Syahida, N.H. Lajis, and S. Khozirah Cardamonin inhibits COX and iNOS expression via inhibition of p65NF-kappaB nuclear translocation and Ikappa-B phosphorylation in RAW 264.7 macrophage cells Mol Immunol 44 2007 673 679
12. S. Joshi, R. Guleria, J. Pan, D. DiPette, and U.S. Singh Retinoic acid receptors and tissue-transglutaminase mediate short-term effect of retinoic acid on migration and invasion of neuroblastoma SH-SY5Y cells Oncogene 25 2006 240 247
13. K.H. Jung, B.H. Park, and S.S. Hong Progress in cancer therapy targeting c-Met signaling pathway Arch Pharm Res 35 2012 595 604
14. S.Y. Kim Transglutaminase 2: a new paradigm for NF-kappaB involvement in disease Adv Enzymol Relat Areas Mol Biol 78 2011 161 195
15. H. Ko, Y.J. Kim, E.C. Amor, J.W. Lee, H.C. Kim, and H.J. Kim Induction of autophagy by dimethyl cardamonin is associated with proliferative arrest in human colorectal carcinoma HCT116 and LOVO cells J Cell Biochem 112 2011 2471 2479
16. T.S. Lai, Y. Liu, T. Tucker, K.R. Daniel, D.C. Sane, and E. Toone Identification of chemical inhibitors to human tissue transglutaminase by screening existing drug libraries Chem Biol 15 2008 969 978
17. C.H. Lee, and S.Y. Kim NF-κB and therapeutic approach Biomol Ther. 17 2009 219 240
18. J.H. Lee, H.S. Jung, P.M. Giang, X. Jin, S. Lee, and P.T. Son Blockade of nuclear factor-kappaB signaling pathway and anti-inflammatory activity of cardamomin, a chalcone analog from Alpinia conchigera J Pharmacol Exp Ther 316 2006 271 278
19. H.L. Lee, M.K. Park, H.C. Bae, H.J. Yoon, S.Y. Kim, and C.H. Lee Transglutaminase-2 is involved in all-trans retinoic acid-induced invasion and matrix metalloproteinases expression of SH-SY5Y neuroblastoma cells via NF-kB pathway Biomol Ther. 20 2012 286 292
20. C.Y. Lin, P.H. Tsai, C.C. Kandaswami, G.D. Chang, C.H. Cheng, and C.J. Huang Role of tissue transglutaminase 2 in the acquisition of a mesenchymal-like phenotype in highly invasive A431 tumor cells Mol Cancer 10 2011 87
21. A. Luciani, V.R. Villella, S. Esposito, N. Brunetti-Pierri, D. Medina, and C. Settembre Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition Nat Cell Biol 12 2010 863 875
22. A. Mazzocca, and V. Carloni The metastatic process: methodological advances and pharmacological challenges Curr Med Chem 16 2009 1704 1717
23. K. Mehta, J. Fok, F.R. Miller, D. Koul, and A.A. Sahin Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer Clin Cancer Res 10 2004 8068 8076
24. M. Mendoza, and C. Khanna Revisiting the seed and soil in cancer metastasis Int J Biochem Cell Biol 41 2009 1452 1462
25. N. Miyoshi, H. Ishii, K. Mimori, F. Tanaka, T. Hitora, and M. Tei TGM2 is a novel marker for prognosis and therapeutic target in colorectal cancer Ann Surg Oncol 17 2010 967 972
26. K. Oh, E. Ko, H.S. Kim, A.K. Park, H.G. Moon, and D.Y. Noh Transglutaminase 2 facilitates the distant hematogenous metastasis of breast cancer by modulating interleukin-6 in cancer cells Breast Cancer Res 13 2011 R96
27. M.K. Park, and C.H. Lee Alpinia katsumadai suppresses migration and 12-O-tetradecanoyl-13-acetate-induced invasion of HT-1080 cells through suppression of transglutaminase-2, matrix metalloproteinase-2, and matrix metalloproteinase-9 expression Cancer Prevention Research 16 2011 326 332
28. D. Park, S.S. Choi, and K.S. Ha Transglutaminase 2: a multi-functional protein in multiple subcellular compartments Amino Acids 39 2010 619 631
29. M.K. Park, H.J. Lee, J. Shin, M. Noh, S.Y. Kim, and C.H. Lee Novel participation of transglutaminase-2 through c-Jun N-terminal kinase activation in sphingosylphosphorylcholine-induced keratin reorganization of PANC-1 cells Biochim Biophys Acta 1811 2011 1021 1029
30. P.S. Steeg Tumor metastasis: mechanistic insights and clinical challenges Nat Med 12 2006 895 904
31. S. Valastyan, and R.A. Weinberg Tumor metastasis: molecular insights and evolving paradigms Cell 147 2011 275 292
32. S. Wang, L. Zhou, W. He, and Z. Hu Separation and determination of alpinetin and cardamonin by reverse micelle electrokinetic capillary chromatography J Pharm Biomed Anal 43 2007 1557 1561
33. X. Wang, N. Lu, B. Niu, X. Chen, J. Xie, and N. Cheng Overexpression of Aurora-A enhances invasion and matrix metalloproteinase-2 expression in esophageal squamous cell carcinoma cells Mol Cancer Res 10 2012 588 596
34. V.R. Yadav, S. Prasad, and B.B. Aggarwal Cardamonin sensitizes tumour cells to TRAIL through ROS- and CHOP-mediated up-regulation of death receptors and down-regulation of survival proteins Br J Pharmacol 165 2012 741 753
35. J. Yang, Y. Dai, Y.F. Xia, W.Z. Huang, and Z.T. Wang Alpinia katsumadai Hayata prevents mouse sepsis induced by cecal ligation and puncture through promoting bacterial clearance and downregulating systemic inflammation Phytother Res 23 2009 267 273
36. L. Yuan, K. Choi, C. Khosla, X. Zheng, R. Higashikubo, and M.R. Chicoine Tissue transglutaminase 2 inhibition promotes cell death and chemosensitivity in glioblastomas Mol Cancer Ther 4 2005 1293 1302